Natera (NTRA) revenue breakdown

Healthcare · Diagnostics & Research · Market cap $57.6B

By product, Product is the largest at 100% of fiscal 2025 revenue, growing 43% a year over 5 years.

By region, United States is the largest at 98% of fiscal 2025 revenue, growing 44% a year over 5 years.

Revenue by product

Fiscal years, as Natera reports them in its 10-K filings; fiscal 2025 total $2.3B.

Products202020212022202320242025Share
Product$378M$580M$797M$1.1B$1.7B$2.3B 100%
Licensing and other$13M$45M$23M$14M$12M$10M 0%

Revenue by region

Fiscal years, as Natera reports them in its 10-K filings; fiscal 2025 total $2.3B.

Regions202020212022202320242025Share
United States$366M$591M$786M$1.0B$1.7B$2.3B 98%
Europe, Middle East, India, and Africa$14M$20M$17M$23M$24M$24M 1%
Americas, excluding U.S.$3M$4M$4M$5M$7M$9M 0%
Asia Pacific and Other$8M$10M$14M$7M$9M$8M 0%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for NTRA.
Open NTRA in Investingly

Questions

Where does Natera make its money?

In fiscal 2025, by product: Product $2.3B, Licensing and other $10M.

From Natera's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.